These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37392902)

  • 1. Prediction of the Time to Reach Equilibrium for Improved Estimation of the Unbound Fraction of Compounds in Equilibrium Dialysis Using kinetic Modeling.
    Bae C; Chung G; Chung SJ
    J Pharm Sci; 2023 Nov; 112(11):2901-2909. PubMed ID: 37392902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties.
    Kalvass JC; Phipps C; Jenkins GJ; Stuart P; Zhang X; Heinle L; Nijsen MJMA; Fischer V
    Drug Metab Dispos; 2018 Apr; 46(4):458-469. PubMed ID: 29437872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.
    Metsu D; Lanot T; Fraissinet F; Picot M; Concordet D; Cabrol M; Dubois-Galopin F; Chatelut E; Delobel P; Gandia P
    Clin Chim Acta; 2018 Apr; 479():56-65. PubMed ID: 29277535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Competitive Equilibrium Dialysis Approach for Assessing the Impact of Protein Binding on Clearance Predictions.
    Jones RS; Chang JH; Flores M; Brecht E
    J Pharm Sci; 2021 Jan; 110(1):536-542. PubMed ID: 32941852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of interpretability of two models of unbound fraction that are used in combination with the well-stirred model for predicting hepatic clearance of drugs.
    Poulin P
    J Pharm Sci; 2024 Nov; 113(11):3177-3190. PubMed ID: 39265660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Plasticizer DEHP in Blood Collection Bags on Human Plasma Fraction Unbound Determination for Alpha-1-Acid Glycoprotein (AAG) Binding Drugs.
    Ingram N; Dishinger C; Wood J; Hutzler JM; Smith S; Huskin M
    AAPS J; 2018 Nov; 21(1):5. PubMed ID: 30446887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of unbound fraction of dorzagliatin in human plasma by equilibrium dialysis and LC-MS/MS and its application to a clinical pharmacokinetic study.
    Yang R; Ren S; Jin X; Sun Y; Dong Y; Zhang J; Liang W; Chen L
    J Pharm Biomed Anal; 2021 Feb; 195():113854. PubMed ID: 33388639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interethnic scaling of fraction unbound of a drug in plasma and volume of distribution: an analysis of extrapolation from Caucasians to Chinese.
    Yu G; Zhou HH; Zheng QS; Li GF
    Eur J Clin Pharmacol; 2019 Apr; 75(4):543-551. PubMed ID: 30569284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.
    Dimitrijevic D; Fabian E; Funk-Weyer D; Landsiedel R
    Biochem Biophys Res Commun; 2023 Apr; 651():114-120. PubMed ID: 36812744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an Additive.
    Srivastava A; Pike A; Williamson B; Fenner K
    J Pharm Sci; 2021 Mar; 110(3):1412-1417. PubMed ID: 33248055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
    Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
    Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between lab variability and
    Fagerholm U; Spjuth O; Hellberg S
    Xenobiotica; 2021 Oct; 51(10):1095-1100. PubMed ID: 34346291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of equilibrium dialysis methods employing biological and artificial membranes for the determination of protein binding of drugs.
    Hinderling PH
    Ther Drug Monit; 1987 Sep; 9(3):331-6. PubMed ID: 3672577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of inactivated brain homogenate to determine the
    Nirogi R; Molgara P; Bhyrapuneni G; Manoharan A; Padala NP; Palacharla VRC
    Xenobiotica; 2020 Oct; 50(10):1228-1235. PubMed ID: 32498645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.